VISCHER is advising Noema Pharma in this transaction. The team is led by Matthias Staehelin (Corporate, pictured left). Walder Wyss advised Gilde Healthcare Partners, Polaris Partners, Invus Capital and BioMedInvest as investors. The team included
Tags :Vischer
The team included Christian Wyss (Partner, Corporate / M&A - pictured), Luzius Zumstein (Senior Associate, Corporate / M&A) and Dario Glauser (Trainee, Corporate / M&A).
The team included Matthias Staehelin (Partner, Corporate - pictured), Sebastian Flückiger (Associate, Corporate), Nadia Tarolli (Partner, Tax) and Adrian Briner (Senior Associate, Tax).
The team was led by Jürg Luginbühl (Partner, Corporate / M&A - pictured) and comprised Christian Gutzwiller (Associate, Corporate / M & A), Michel Stübi (Associate, Corporate / M&A), Rolf Auf der Maur (Partner,
VISCHER advises T3 Pharmaceuticals on all legal issues in connection with the transaction. The team consists of Christian Wyss (Partner, Corporate / M&A - pictured), Pauline Pfirter (Associate, Corporate / M&A), Ruben Masar (Associate, Corporate /
The team included Matthias Staehelin (pictured), Angelo Imperiale and Sebastian Flückiger (all Corporate) as well as Nadia Tarolli and Adrian Briner (both Tax).
The team included partner Matthias Staehelin (pictured), managing associates Moritz Jäggy and Dania Salvisberg-Schneider (all Corporate).
The team was led by partner Jürg Luginbühl (Corporate/M&A - pictured) and included associate Christian Gutzwiller (Corporate/M&A), senior associate Elias Mühlemann (TMT) and associate Michel Stübi (Corporate/
The team included partner Matthias Staehelin and associate Timothy Woodtli (both Corporate).
The team included partner Christian Wyss (Life Sciences - pictured), associate Timothy Woodtli (Corporate/M&A), associate Francesca Pesenti (Corporate/M&A), and associate Gian Geel (Employment).
